The ESMO Advanced Course on Early Stage Non-Small-Cell Lung Cancer 2026 is an intensive educational meeting scheduled to take place from April 23–24, 2026, in Athens, Greece.

Under the leadership of Co-Chairs Helena Linardou, Giannis Mountzios, and Solange Peters, this course is designed to provide oncology professionals with a comprehensive update on the rapidly evolving diagnostic and therapeutic standards for early-stage NSCLC.

The program typically emphasizes multidisciplinary management, covering advancements in neoadjuvant and adjuvant systemic therapies, surgical innovations, and the integration of molecular profiling to personalize patient care. Through a combination of expert lectures and interactive discussions, the event aims to bridge the gap between clinical trial data and real-world practice to improve outcomes for patients with resectable lung cancer.

Application.